Publications | Page 371 | Pathology & Laboratory Medicine

Filter By Faculty

Filter by Principal Investigator

Neto BS, Smith GL, Mandeville JA, Vanni AJ, Wotkowicz C, Rieger-Christ KM, et al. Prognostic significance of altered p120 ctn expression in bladder cancer. BJU Int. 2008;101(6):746-52.

Yemelyanova AV, Cosin JA, Bidus MA, Boice CR, Seidman JD. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008;18(3):465-9.

Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik J-, Ying H, et al. Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A. 2008;105(49):19372-7.

Leone PE, Walker BA, Jenner MW, Chiecchio L, Dagrada G, Protheroe RK, et al. Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res. 2008;14(19):6033-41.

Rutherford SC, Andemariam B, Philips SM, Elstrom RL, Chadburn A, Furman RR, et al. FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leuk Lymphoma. 2008;49(4):719-26.

Magro CM, Dyrsen M, Kerns MJ. Cutaneous lesions of dermatomyositis with supervening fibrosis. J Cutan Pathol. 2008;35(1):31-9.

Ince TA, Ward JM, Valli VE, Sgroi D, Nikitin AY, Loda M, et al. Do-it-yourself (DIY) pathology. Nat Biotechnol. 2008;26(9):978-9; discussion 979.

Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology. 2008;248(3):807-16.